Literature DB >> 10964702

Affinity maturation of natural antibody using a chain shuffling technique and the expression of recombinant antibodies in Escherichia coli.

S G Park1, J S Lee, E Y Je, I J Kim, J H Chung, I H Choi.   

Abstract

The affinity of natural antibody (Ka = 8 x 10(6) M(-1)) recognizing preS1 of hepatitis B virus (HBV) was improved by replacing the heavy (H) chain gene with repertoires of VH genes, obtained from two nonimmunized donors. Two separate clones, 1C2 and 1E4, showed affinities of 2.3 x 10(7) and 5.2 x 10(7) M(-1), which were increased by factors of 2.8 and 6.5, respectively, compared to the parental clone. Recombinant scFvs (rscFvs) were expressed as fusion protein with minor coat protein, pIII, and secreted into medium after 3 h of induction with 1 mM IPTG. The expression level of functional rscFv capable of binding to preS1 reached a peak after 6-10 h (1C2) and 8-10 h (1E4) of IPTG induction, and afterwards decreased gradually. In order to achieve the overexpression of rscFv in E. coli, gene encoding scFv of 1C2 or 1E4 was inserted into pRSET vector. RscFvs were overexpressed as cytoplasmic inclusion bodies in E. coli BL 21 strain, which were denatured and carefully refolded using a continuous dialysis system. The purified recombinant fragments were pure when analyzed by SDS-PAGE and had the predicted size of 34 kDa. Clone 1E4 used the heavy chain gene belonging to family VII and subgroup III. Chain shuffling offers an alternative to random point mutation for affinity maturation of human antibody in vitro. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964702     DOI: 10.1006/bbrc.2000.3336

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Single-chain antibody fragment specific for Plasmodium vivax Duffy binding protein.

Authors:  So-Hee Kim; Seung-Young Hwang; Yong-Seok Lee; In-Hak Choi; Sae-Gwang Park; Weon-Gyu Kho
Journal:  Clin Vaccine Immunol       Date:  2007-04-25

2.  Rise and fall of an anti-MUC1 specific antibody.

Authors:  Holger Thie; Lars Toleikis; Jiandong Li; Reinhard von Wasielewski; Gunther Bastert; Thomas Schirrmann; Isabel Tourais Esteves; Christian K Behrens; Bénédict Fournes; Nathalie Fournier; Christophe de Romeuf; Michael Hust; Stefan Dübel
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

Review 3.  scFv antibody: principles and clinical application.

Authors:  Zuhaida Asra Ahmad; Swee Keong Yeap; Abdul Manaf Ali; Wan Yong Ho; Noorjahan Banu Mohamed Alitheen; Muhajir Hamid
Journal:  Clin Dev Immunol       Date:  2012-03-15

4.  Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs.

Authors:  Andre A R Teixeira; Sara D'Angelo; M Frank Erasmus; Camila Leal-Lopes; Fortunato Ferrara; Laura P Spector; Leslie Naranjo; Esteban Molina; Tamara Max; Ashley DeAguero; Katherine Perea; Shaun Stewart; Rebecca A Buonpane; Horacio G Nastri; Andrew R M Bradbury
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.